Furiex Pharmaceuticals, Inc. is a drug development collaboration company using innovative clinical development design to accelerate and increase the value of partnered drug programs by advancing them to the market in a cost-efficient manner.
EXPERT. FOCUSED. FAST.
23 Jan >> Furiex Pharmaceuticals Announces Fourth Quarter and Full Year 2011 Earnings Release and Conference Call More details >
08 Dec >> Furiex Announces Results for Phase II Trial of PPD-10558 More details >
23 Nov >> Furiex Confirms Takeda’s Submission of Alogliptin/Metformin Fixed Dose Combination NDA to the U.S. Food and Drug Administration More details >